The global breast imaging market size was estimated to be USD 5.48 billion in 2023 and is expected to reach at USD 14.03 billion by 2034 with a CAGR of 8.92% during the forecast period 2024-2034. Surge in prevalence of breast cancer, rising technological advancements in breast imaging, growing investment by several organizations in breast cancer screening programs, increasing demand for early diagnosis of breast cancer, surge in awareness initiatives & campaigns regarding breast cancer by numerous organizations, rising technological developments in imaging technology, growing research activities for the development of hybrid imaging systems, increasing launch of new products to improve the sensitivity & precision of breast cancer diagnostics, surge in adoption of sophisticated imaging systems, and rising approval of advanced breast imaging platforms by regulatory authorities are some of the key factors boosting the market growth.
Rising approval of advanced breast imaging platforms by regulatory authorities is predicted to boost the market growth during the forecast period. Breast imaging technologies are employed to examine women's breast tissues for the detection of breast cancer and other related conditions. Frequently employed breast imaging examinations encompass mammograms, breast magnetic resonance imaging (MRI), and ultrasound scans. Furthermore, computed tomography scans (CT scans) and positron emission tomography (PET) are recommended for breast cancer diagnosis. Mammography, a type of breast imaging technology, utilizes low-dose X-rays to detect cancer in its early stages, even before symptoms appear. Consequently, industry stakeholders are prioritizing the advancement of state-of-the-art technologies in this field. For instance, in January 2023, QmTriage, an AI platform with a focus on breast cancer developed in collaboration between MedCognetics and the University of Texas Southwestern (UTSW) Medical Centre, has received clearance from the FDA.
By product, software & services was the highest revenue-grossing segment in the global breast imaging market in 2023 owing to the surge in integration of advanced functionalities into the software modules to enable precise detection, and increasing collaborations within market players. For instance, in August 2023, iCAD, Inc., a prominent global medical technology company known for its inventive cancer detection and treatment solutions, has disclosed an amendment to its development and commercialization agreement with Google Health. This amendment grants iCAD the capability to incorporate Google's AI technology into its ProFound Breast Health Suite for 2D Mammography on a global scale once it receives regulatory clearance. The integration will enable it to serve as an independent reader for breast cancer screening for a period of 20 years. Additionally, breast imaging system is predicted to grow at fastest CAGR during the forecast period owing to the increasing technological developments, rising focus on development of cutting-edge technologies, and growing introduction of advanced systems.
By technology, ionizing was the highest revenue-grossing segment in the global breast imaging market in 2023 owing to the rising introduction of advanced ionizing technology-based breast imaging technologies, increasing funding for the advancements in currently available ionization-based technologies, and growing demand for mammography screening. Additionally, non-ionizing is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements and increasing focus on development of new medical imaging technologies. For instance, in May 2022, The Barcelona Supercomputing Center (BSC) is leading the coordination of the QUSTom (Quantitative Ultrasound Stochastic Tomography) project, a novel European initiative. This project intends to introduce a fresh approach to medical imaging, utilizing ultrasound and supercomputing, which has the potential to supplement or potentially supplant existing X-ray-based techniques like mammograms.
By end-user, hospitals was the highest revenue-grossing segment in the global breast imaging market in 2023 owing to the availability of cutting-edge and well-equipped breast imaging equipment inside a hospital, increasing investments in healthcare infrastructures & diagnostic equipment, and rising introduction of advanced imaging devices. For instance, in March 2022, Scientists at the University of Notre Dame have developed an innovative imaging tool called the NearWave Imager, designed to detect breast cancer without the need for invasive procedures. Additionally, diagnostic imaging centers is predicted to grow at fastest CAGR during the forecast period owing to the rising awareness regarding breast cancer, growing demand for breast imaging procedures for early diagnosis, treatment planning, & prevention of breast cancer.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of breast cancer, increasing research & development activities, surge in number of diagnostic screenings performed, rising focus on development of new technologies for breast imaging, and growing approvals by regulatory bodies. For instance, in May 2022, The US Food and Drug Administration has granted approval for the ATUSA, a portable system by iSono Health that autonomously scans the entire breast and delivers a three-dimensional image of breast tissue. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing investment in research & development activities, rising adoption of cutting-edge technologies, surge in prevalence of breast cancer, expanding healthcare infrastructure, growing demand for breast imaging technologies, and increasing launch of advanced systems. for instance, in February 2023, FUJIFILM India showcased its most recent healthcare medical equipment, including the Full Field Digital Mammography (FFDM) device known as Amulet Innovality. This state-of-the-art Amulet Innovality represents an advanced diagnostic tool for detecting breast cancer early, offering women the opportunity for early detection.
Rising approval of advanced breast imaging platforms by regulatory authorities is predicted to boost the market growth during the forecast period. Breast imaging technologies are employed to examine women's breast tissues for the detection of breast cancer and other related conditions. Frequently employed breast imaging examinations encompass mammograms, breast magnetic resonance imaging (MRI), and ultrasound scans. Furthermore, computed tomography scans (CT scans) and positron emission tomography (PET) are recommended for breast cancer diagnosis. Mammography, a type of breast imaging technology, utilizes low-dose X-rays to detect cancer in its early stages, even before symptoms appear. Consequently, industry stakeholders are prioritizing the advancement of state-of-the-art technologies in this field. For instance, in January 2023, QmTriage, an AI platform with a focus on breast cancer developed in collaboration between MedCognetics and the University of Texas Southwestern (UTSW) Medical Centre, has received clearance from the FDA.
By product, software & services was the highest revenue-grossing segment in the global breast imaging market in 2023 owing to the surge in integration of advanced functionalities into the software modules to enable precise detection, and increasing collaborations within market players. For instance, in August 2023, iCAD, Inc., a prominent global medical technology company known for its inventive cancer detection and treatment solutions, has disclosed an amendment to its development and commercialization agreement with Google Health. This amendment grants iCAD the capability to incorporate Google's AI technology into its ProFound Breast Health Suite for 2D Mammography on a global scale once it receives regulatory clearance. The integration will enable it to serve as an independent reader for breast cancer screening for a period of 20 years. Additionally, breast imaging system is predicted to grow at fastest CAGR during the forecast period owing to the increasing technological developments, rising focus on development of cutting-edge technologies, and growing introduction of advanced systems.
By technology, ionizing was the highest revenue-grossing segment in the global breast imaging market in 2023 owing to the rising introduction of advanced ionizing technology-based breast imaging technologies, increasing funding for the advancements in currently available ionization-based technologies, and growing demand for mammography screening. Additionally, non-ionizing is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements and increasing focus on development of new medical imaging technologies. For instance, in May 2022, The Barcelona Supercomputing Center (BSC) is leading the coordination of the QUSTom (Quantitative Ultrasound Stochastic Tomography) project, a novel European initiative. This project intends to introduce a fresh approach to medical imaging, utilizing ultrasound and supercomputing, which has the potential to supplement or potentially supplant existing X-ray-based techniques like mammograms.
By end-user, hospitals was the highest revenue-grossing segment in the global breast imaging market in 2023 owing to the availability of cutting-edge and well-equipped breast imaging equipment inside a hospital, increasing investments in healthcare infrastructures & diagnostic equipment, and rising introduction of advanced imaging devices. For instance, in March 2022, Scientists at the University of Notre Dame have developed an innovative imaging tool called the NearWave Imager, designed to detect breast cancer without the need for invasive procedures. Additionally, diagnostic imaging centers is predicted to grow at fastest CAGR during the forecast period owing to the rising awareness regarding breast cancer, growing demand for breast imaging procedures for early diagnosis, treatment planning, & prevention of breast cancer.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of breast cancer, increasing research & development activities, surge in number of diagnostic screenings performed, rising focus on development of new technologies for breast imaging, and growing approvals by regulatory bodies. For instance, in May 2022, The US Food and Drug Administration has granted approval for the ATUSA, a portable system by iSono Health that autonomously scans the entire breast and delivers a three-dimensional image of breast tissue. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing investment in research & development activities, rising adoption of cutting-edge technologies, surge in prevalence of breast cancer, expanding healthcare infrastructure, growing demand for breast imaging technologies, and increasing launch of advanced systems. for instance, in February 2023, FUJIFILM India showcased its most recent healthcare medical equipment, including the Full Field Digital Mammography (FFDM) device known as Amulet Innovality. This state-of-the-art Amulet Innovality represents an advanced diagnostic tool for detecting breast cancer early, offering women the opportunity for early detection.
Segmentation: Breast Imaging Market Report 2023 - 2034
Breast Imaging Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Breast Imaging System
- Software & Services
- Accessories
Breast Imaging Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Ionizing
- Analog Mammography
- Positron Emission Mammography
- Full-field Digital Mammography
- MBI/BSGI
- Electric Impedance Tomography
- 3D Breast Tomosynthesis
- Cone-Beam Computed Tomography
- Positron Emission Tomography & Computed Tomography
- Non-Ionizing
- Thermography
- Ultrasound
- MRI
- Optical Imaging
- Automated Whole-breast Ultrasound
Breast Imaging Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Breast Care Centers
- Hospitals
- Diagnostic Imaging Centers
Breast Imaging Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Breast Imaging Market: Product Estimates & Trend Analysis
8. Breast Imaging Market: Technology Estimates & Trend Analysis
9. Breast Imaging Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Breast Imaging Market
12. Europe Global Breast Imaging Market
13. Asia Pacific Global Breast Imaging Market
14. Latin America Global Breast Imaging Market
15. MEA Global Breast Imaging Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Fujifilm Holdings Corp.
- GE Healthcare
- Siemens Healthcare
- SonoCine Inc.
- Aurora Imaging Technology Inc.
- Philips Healthcare
- Hologic Inc.
- Toshiba Corporation
- Gamma Medica Inc.
- Dilon Technologies Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 5.48 Billion |
| Forecasted Market Value ( USD | $ 14.03 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
